|
70066-T
|
Biotium
|
LysoView 405, 1000X in DMSO
|
|
|
|
|
70066
|
Biotium
|
LysoView 405, 1000X in DMSO
|
|
|
|
|
30092-T
|
Biotium
|
MemBrite Fix 405/430, 100 labelings
|
|
|
|
|
30092
|
Biotium
|
MemBrite Fix 405/430, 500 labelings
|
|
|
|
|
70070-T
|
Biotium
|
MitoView 405
|
|
|
|
|
70070
|
Biotium
|
MitoView 405 (20 x 50ul)
|
|
|
|
|
10407
|
Biotium
|
NucView 405 Caspase-3 Substrate, 1 mM in 1X PBS
|
|
|
|
|
10407-T
|
Biotium
|
NucView 405 Caspase-3 Substrate, 1 mM in 1X PBS, Trial Size
|
|
|
|
|
10405
|
Biotium
|
NucView 405 Caspase-3 Substrate, 1 mM in DMSO
|
|
|
|
|
10405-T
|
Biotium
|
NucView 405 Caspase-3 Substrate, 1 mM in DMSO, Trial Size
|
|
|
|
|
00034-T
|
Biotium
|
Phalloidin, CF405M
|
|
|
|
|
70064-T
|
Biotium
|
ViaFluor 405 Live Cell Microtubule Stain
|
|
|
|
|
70064
|
Biotium
|
ViaFluor 405 Live Cell Microtubule Stain, Trial Size
|
|
|
|
|
30068
|
Biotium
|
ViaFluor 405-SE Cell Proliferation Kit
|
|
|
|
|
30068-T
|
Biotium
|
ViaFluor 405-SE Cell Proliferation Kit (Trial size)
|
|
|
|
|
AR4010-50
|
Boster Biological Technology
|
Caspase-10 Activity Assay Kit [50 assays]
|
|
Enzyme Activity
|
|
|
AR4004-50
|
Boster Biological Technology
|
Caspase-2 Activity Assay Kit [50 assays]
|
|
Enzyme Activity
|
|
|
AR4005-50
|
Boster Biological Technology
|
Caspase-3, 7 Activity Assay Kit [50 assays]
|
|
Enzyme Activity
|
|
|
AR4006-50
|
Boster Biological Technology
|
Caspase-4 Activity Assay Kit [50 assays]
|
|
Enzyme Activity
|
|
|
AR4009-50
|
Boster Biological Technology
|
Caspase-6 Activity Assay Kit [50 assays]
|
|
Enzyme Activity
|
|
|
AR4007-50
|
Boster Biological Technology
|
Caspase-8 Activity Assay Kit [50 assays]
|
|
Enzyme Activity
|
|
|
AR4008-50
|
Boster Biological Technology
|
Caspase-9 Activity Assay Kit [50 assays]
|
|
Enzyme Activity
|
|
|
HY-W114781-10g
|
MedChemexpress LLC
|
4-Fluoro-N-methylbenzylamine [CAS 405-66-3]
|
|
|
|
|
HY-W114781-5g
|
MedChemexpress LLC
|
4-Fluoro-N-methylbenzylamine [CAS 405-66-3]
|
|
|
|
|
HY-120833-1mg
|
MedChemexpress LLC
|
Ac-Ile-Glu-Thr-Asp-pNA [CAS 219138-21-3]
|
|
|
|
